CAD 0.07
(-30.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 2.99 Million CAD | 16.01% |
2022 | 2.58 Million CAD | 510.8% |
2021 | 423.35 Thousand CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 2.99 Million CAD | -0.05% |
2024 Q1 | 2.99 Million CAD | -0.0% |
2024 Q3 | 2.99 Million CAD | 0.04% |
2023 Q3 | 2.96 Million CAD | 6.41% |
2023 FY | 2.99 Million CAD | 16.01% |
2023 Q4 | 2.99 Million CAD | 1.08% |
2023 Q2 | 2.78 Million CAD | -1.14% |
2023 Q1 | 2.82 Million CAD | 9.1% |
2022 Q1 | 2.26 Million CAD | 434.6% |
2022 FY | 2.58 Million CAD | 510.8% |
2022 Q4 | 2.58 Million CAD | -0.04% |
2022 Q3 | 2.58 Million CAD | 10.44% |
2022 Q2 | 2.34 Million CAD | 3.49% |
2021 Q1 | -1.04 Million CAD | 0.0% |
2021 Q4 | 423.35 Thousand CAD | 93.13% |
2021 Q2 | -626.15 Thousand CAD | 39.8% |
2021 FY | 423.35 Thousand CAD | 0.0% |
2021 Q3 | 219.21 Thousand CAD | 135.01% |
2020 FY | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -125.08 Thousand CAD | 2498.164% |
Asep Medical Holdings Inc | -44.72 Thousand CAD | 6807.683% |
BetterLife Pharma Inc. | 207.85 Thousand CAD | -1343.225% |
BioVaxys Technology Corp. | -977.00 CAD | 307136.131% |
ChitogenX Inc. | 3.84 Million CAD | 21.882% |
Rapid Dose Therapeutics Corp. | 2.29 Million CAD | -30.844% |
Defence Therapeutics Inc. | 1.68 Million CAD | -77.51% |
Entheon Biomedical Corp. | -344.63 Thousand CAD | 970.417% |
Gemina Laboratories Ltd. | 284.33 Thousand CAD | -954.999% |
Glow Lifetech Corp. | 116.15 Thousand CAD | -2482.646% |
Lexston Life Sciences Corp. | -390.4 Thousand CAD | 868.367% |
Pharmala Biotech Holdings Inc. | 58.49 Thousand CAD | -5028.204% |
Doseology Sciences Inc. | -1.06 Million CAD | 382.935% |
Nova Mentis Life Science Corp. | -8088.00 CAD | 37188.811% |
PharmaTher Holdings Ltd. | -2.13 Million CAD | 240.62% |
PreveCeutical Medical Inc. | 3.83 Million CAD | 21.734% |
Telescope Innovations Corp. | -719.49 Thousand CAD | 516.925% |